Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Saraiva

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Neuromuscular Disorders : NMD|January 1, 1991
Recent advances in the molecular pathology of familial amyloid polyneuropathyM J Saraiva
Human Mutation|June 1, 2001
Transthyretin mutations in hyperthyroxinemia and amyloid diseasesM J Saraiva
FEBS Letters|June 20, 2001
Transthyretin amyloidosis: a tale of weak interactionsM J Saraiva
Human Mutation|January 1, 1995
Transthyretin mutations in health and diseaseM J Saraiva
American Journal of Medical Genetics|June 1, 1987
Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade)J Sequeiros, M J Saraiva
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 2, 2006
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice modelI Cardoso, M J Saraiva
Neuroscience|June 9, 2004
Enlarged ventricles, astrogliosis and neurodegeneration in heat shock factor 1 null mouse brainS D Santos, M J Saraiva
The Journal of Biological Chemistry|March 30, 2001
Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptorM M Sousa, M J Saraiva
European Journal of Endocrinology|August 1, 1996
Thyroxine binding to transthyretin (TTR) variants--two variants (TTR Pro 55 and TTR Met 111) with a particularly low binding affinityM R Almeida, M J Saraiva
Journal of Structural Biology|August 15, 2000
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategiesA M Damas, M J Saraiva
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Neuromuscular Disorders : NMD|January 1, 1991
Recent advances in the molecular pathology of familial amyloid polyneuropathyM J Saraiva
Human Mutation|June 1, 2001
Transthyretin mutations in hyperthyroxinemia and amyloid diseasesM J Saraiva
FEBS Letters|June 20, 2001
Transthyretin amyloidosis: a tale of weak interactionsM J Saraiva
Human Mutation|January 1, 1995
Transthyretin mutations in health and diseaseM J Saraiva
American Journal of Medical Genetics|June 1, 1987
Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade)J Sequeiros, M J Saraiva
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 2, 2006
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice modelI Cardoso, M J Saraiva
Neuroscience|June 9, 2004
Enlarged ventricles, astrogliosis and neurodegeneration in heat shock factor 1 null mouse brainS D Santos, M J Saraiva
The Journal of Biological Chemistry|March 30, 2001
Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptorM M Sousa, M J Saraiva
European Journal of Endocrinology|August 1, 1996
Thyroxine binding to transthyretin (TTR) variants--two variants (TTR Pro 55 and TTR Met 111) with a particularly low binding affinityM R Almeida, M J Saraiva
Journal of Structural Biology|August 15, 2000
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategiesA M Damas, M J Saraiva
Pageof 11